A case report can identify an important warning signal without establishing how often an outcome occurs or proving a single cause. That distinction is essential when discussing melanoma: exaggeration can mislead, but dismissing a report because it is not a trial can also miss a serious concern.
The published melanotan II case report described melanoma in a person who had also used tanning beds. The authors reported the co-occurrence and raised concern. The report did not independently randomize the peptide and UV exposure, so it cannot isolate their separate contributions or provide a relative-risk estimate.
The FDA safety discussion includes melanoma among serious events discussed in published reports. Inclusion signals a reason for caution and review; it is not a statement that every changing mole is melanoma or that a precise causal percentage has been established.
Several questions are easily conflated. Did exposure precede diagnosis? Was the lesion present beforehand? Were other risk factors involved? Was the actual product identified? Did increased attention lead to earlier detection? A case history may address some of these questions while leaving others unresolved.
For an individual, uncertainty about causation does not remove the need to assess a changing lesion. A dermatologist evaluates the lesion itself and the person's history. The clinical decision should not wait for researchers to settle the population-level causal debate, nor should a forum image be treated as a diagnosis.
The opposite inference is also unsound: if a study has not proved a particular risk, that does not demonstrate safety. Establishing safety would require adequate observation, reliable exposure information and suitable comparison data. A gap in evidence is not a protective finding.
The balanced conclusion is that the reports warrant attention while their limitations remain explicit. This article neither declares that every exposure causes cancer nor offers a way to use melanotan II safely. It explains why skin changes deserve proper assessment and why serious-event reports cannot be reduced to either certainty or reassurance.